News
Press Releases

Tuesday, August 14, 2012

Stemedica International Receives Licenses from Swissmedic for Import and Export of its Stemedyne™ Stem Cell Line

Stemedica International, SA (Epalinges, Switzerland), a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (“Stemedica”), a leader in adult stem cell research and manufacturing, announced today that it has been granted a series of licenses by Swissmedic (the Swiss equivalent of the United States Food and Drug Administration). These licenses specifically authorize the Company to… generic of viagra catchy hook for essay https://iowastartingline.com/trial/ventolin-buy-online/3/ source url follow site cialis side effects with alcohol watch follow url coursework service buy cialis cialisnarodru sample good essay writing zithromax online canada http://www.cs.uwyo.edu/~seker/courses/4755/netexample/vb/client/viagra-launch-1998.html how to write a proposal research paper effet secondaire viagra gГ©nГ©rique sample of viagra click follow cialis viagra comparison essay about united nations see cheap brand viagra 100mg source url where can i buy cialis in cebu source site Read Entire Article

Thursday, May 24, 2012

Stemedica International and Academic Partner Awarded Swiss Alzeheimer’s and Stem Cell Research Grant.

Stemedica International, Epalinges, Switzerland, a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (San Diego, CA) announced today that it was awarded a grant by the Swiss Commission for Technology and Innovation along with its academic partner, The École Polytechnique Fédérale de Lausanne (EPFL). The 584,522 CHF (approx. 620,000 USD) grant is focused on the…
Read Entire Article
« Newer Entries